Back to all papers

Deep Learning-Based Automated Segmentation of Uterine Myomas

Authors

Tausifa Jan Saleem,Mohammad Yaqub

Abstract

Uterine fibroids (myomas) are the most common benign tumors of the female reproductive system, particularly among women of childbearing age. With a prevalence exceeding 70%, they pose a significant burden on female reproductive health. Clinical symptoms such as abnormal uterine bleeding, infertility, pelvic pain, and pressure-related discomfort play a crucial role in guiding treatment decisions, which are largely influenced by the size, number, and anatomical location of the fibroids. Magnetic Resonance Imaging (MRI) is a non-invasive and highly accurate imaging modality commonly used by clinicians for the diagnosis of uterine fibroids. Segmenting uterine fibroids requires a precise assessment of both the uterus and fibroids on MRI scans, including measurements of volume, shape, and spatial location. However, this process is labor intensive and time consuming and subjected to variability due to intra- and inter-expert differences at both pre- and post-treatment stages. As a result, there is a critical need for an accurate and automated segmentation method for uterine fibroids. In recent years, deep learning algorithms have shown re-markable improvements in medical image segmentation, outperforming traditional methods. These approaches offer the potential for fully automated segmentation. Several studies have explored the use of deep learning models to achieve automated segmentation of uterine fibroids. However, most of the previous work has been conducted using private datasets, which poses challenges for validation and comparison between studies. In this study, we leverage the publicly available Uterine Myoma MRI Dataset (UMD) to establish a baseline for automated segmentation of uterine fibroids, enabling standardized evaluation and facilitating future research in this domain.

Topics

eess.IV

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.